Edwards Lifesciences Raises Guidance with Revenue Above Estimates

Tue. July 22, 2008; Posted: 04:49 PM

7 Stocks You Need To Know For Tomorrow -- Free Newsletter

Jul 22, 2008 (EarningsWhispers Guidance Summaries via Comtex) -- EW | Quote | Chart | News | PowerRating -- Edwards Lifesciences (NYSE: EW | Quote | Chart | News | PowerRating) said it expects third quarter earnings of $0.53 to $0.57 per share. The current consensus earnings estimate is $0.56 per share on revenue of $295.1 million for the quarter ending September 30, 2008. The company also said it expects 2008 earnings of $2.50 to $2.58 per share on revenue of $1.24 billion to $1.28 billion. The company's previous guidance was earnings of $2.45 to $2.53 per share on revenue of $1.21 billion to $1.26 billion and the current consensus earnings estimate is $2.50 per share on revenue of $1.23 billion for the year ending December 31, 2008.

This earnings guidance summary was provided by EarningsWhispers, a leading provider of earnings expectations - including corporate guidance announcements and analysts' expectations that differ from published estimates. http://www.earningswhispers.com

For full details on Edwards Life Sciences (EW) click here. Edwards Life Sciences (EW) has Short Term PowerRatings of 8. Details on Edwards Life Sciences (EW) Short Term PowerRatings is available at This Link.

Morning Coffee with TradingMarkets -- Free Newsletter

More News: Market Updates | Stock Alerts | All Trading News | Stock Index

Archives

Feedback

Email Article Link

Close X

RELATED SITES

Please call 1-213-955-5858 ext. 1

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.